Cessatech A/S Stock

Stocks

End-of-day quote NORDIC GROWTH MARKET Other stock markets 25/06/2026			5-day change	1st Jan Change
21.00 ^DKK	+7.97%		+10.53%	+31.58%

06-12	Cessatech partners with Rigshospitalet for CT004 development	FW
06-12	Cessatech A/S and University Hospital of Copenhagen, Rigshospitalet Enter Collaboration to Advance Intravenous Formulation of Melatonin for Post-Anaesthesia Delirium in Children	CI

Timeframe

Style

06-12	Cessatech partners with Rigshospitalet for CT004 development	FW
06-12	Cessatech A/S and University Hospital of Copenhagen, Rigshospitalet Enter Collaboration to Advance Intravenous Formulation of Melatonin for Post-Anaesthesia Delirium in Children	CI
05-28	Cessatech narrows losses	FW
05-28	Cessatech A/S Reports Earnings Results for the First Quarter Ended March 31, 2026	CI
02-27	Cessatech A/S Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2025	CI
02-27	Cessatech's Operating Loss Decreased in 2025	FW
02-27	Cessatech A/S Auditor Raises 'Going Concern' Doubt	CI
11-13	Cessatech A/S Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	CI
11-13	Cessatech increases operating loss	FW
31/10/25	Cessatech Nears Launch of Pediatric Pain Medication in US Market	FW
21/08/25	Cessatech A/S Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025	CI
21/08/25	Cessatech Narrows Losses in Second Quarter	FW
15/08/25	Cessatech Submits Application to EMA for CT001 Pediatric Pain Relief	FW

06-12	Cessatech enters collaboration with University Hospital of Copenhagen, Rigshospitalet, to advance an intravenous formulation of melatonin for post-anaesthesia delirium (CT004) in children	AQ
05-28	First Quarter Report Q1-2026	AQ
03-30	Minutes from the Annual General Meeting in Cessatech A/S	AQ
03-13	Cessatech convenes its Annual General Meeting	AQ
02-27	Cessatech A/S Announces Financial Results for the Full Year 2025	AQ

Manager	Title	Age	Since
Jes Trygved CEO	Chief Executive Officer	53	01/01/2020
Sarah Margaux Toft-Jørgensen DFI	Director of Finance/CFO	-	01/11/2025
Martin Juhl CTO	Chief Tech/Sci/R&D Officer	-	01/03/2022

Director	Title	Age	Since
Martin Olin CHM	Chairman	57	01/01/2022
Flemming Steen Jensen BRD	Director/Board Member	65	01/01/2020
Charlotte Videbaek BRD	Director/Board Member	64	01/01/2020